Facile tumor spheroids formation in large quantity with controllable size and high uniformity W Shi, J Kwon, Y Huang, J Tan, CG Uhl, R He, C Zhou, Y Liu Scientific reports 8 (1), 6837, 2018 | 67 | 2018 |
Magnetic particles assisted capture and release of rare circulating tumor cells using wavy-herringbone structured microfluidic devices W Shi, S Wang, A Maarouf, CG Uhl, R He, D Yunus, Y Liu Lab on a Chip 17 (19), 3291-3299, 2017 | 51 | 2017 |
Mechanical response of cardiovascular stents under vascular dynamic bending J Xu, J Yang, N Huang, C Uhl, Y Zhou, Y Liu Biomedical engineering online 15, 1-20, 2016 | 48 | 2016 |
Microfluidic device for expedited tumor growth towards drug evaluation CG Uhl, Y Liu Lab on a Chip 19 (8), 1458-1470, 2019 | 30 | 2019 |
The shape effect on polymer nanoparticle transport in a blood vessel CG Uhl, Y Gao, S Zhou, Y Liu RSC advances 8 (15), 8089-8100, 2018 | 30 | 2018 |
Fabrication of circular microfluidic channels through grayscale dual-projection lithography R He, D Yunus, C Uhl, W Shi, S Sohrabi, Y Liu Microfluidics and Nanofluidics 21, 1-10, 2017 | 22 | 2017 |
Biomimetic microfluidic platform for the quantification of transient endothelial monolayer permeability and therapeutic transport under mimicked cancerous conditions CG Uhl, VR Muzykantov, Y Liu Biomicrofluidics 12 (1), 2018 | 18 | 2018 |
Bi-layer blood vessel mimicking microfluidic platform for antitumor drug screening based on co-culturing 3D tumor spheroids and endothelial layers W Shi, L Reid, Y Huang, CG Uhl, R He, C Zhou, Y Liu Biomicrofluidics 13 (4), 2019 | 15 | 2019 |
Theoretical analysis of the cooling performance of a thermoelectric element with temperature-dependent material properties C Ju, X Wang, G Dui, CG Uhl, L Xin Journal of Electronic Materials 48, 4627-4636, 2019 | 11 | 2019 |
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma C Cultrara, C Uhl, K Kirby, EA Elrazaq, A Zellander, DW Andrews, ... Journal for Immunotherapy of Cancer 11 (8), 2023 | 7 | 2023 |
Organ-on-chip devices toward applications in drug development and screening C Uhl, W Shi, Y Liu Journal of Medical Devices 12 (4), 040801, 2018 | 6 | 2018 |
Performance analysis of a functionally graded thermoelectric element with temperature-dependent material properties C Ju, G Dui, CG Uhl, L Chu, X Wang, Y Liu Journal of Electronic Materials 48, 5542-5554, 2019 | 5 | 2019 |
Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production C Uhl, T Nyirenda, DS Siegel, WY Lee, J Zilberberg Heliyon 8 (3), 2022 | 4 | 2022 |
Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma (IGV-001) protects mice against other lethal solid tumor challenges J Zilberberg, A Zellander, C Uhl, C Cultrara, K Kirby, E Elazaq, CB Scott, ... Cancer Research 82 (12_Supplement), 626-626, 2022 | 3 | 2022 |
218 Autologous glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect against tumor challenge and generate T cell … J Zilberberg, A Zellander, K Kirby, C Uhl, C Cultrara, C Scott, D Andrews, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 3 | 2021 |
1398 Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma protects mice against ovarian liver and bladder cancer tumor challenges A Zellander, C Uhl, C Cultrara, K Kirby, E Elrazaq, C Scott, D Andrews, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 2 | 2022 |
ROS-Dependent Activation of Immunogenic Glioblastoma Cell Death and Release of Immunogenic Particles by an Autologous Cell-Based Immunotherapeutic Platform C Cultrara, K Kirby, E Elrazaq, C Uhl, A Zellander, L Galluzzi, M Exley, ... Cancer Research 83 (7_Supplement), 1812-1812, 2023 | | 2023 |
1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes C Cultrara, K Kirby, E Elrazaq, C Uhl, A Zellander, L Galluzzi, M Exley, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
Machine learning algorithm identifies key serum cytokines associated with evidence of clinical activity in patients treated with personalized immunotherapeutic platform (IGV-00) C Uhl, J Zilberberg, CB Scott, DW Andrews, M Exley Cancer Research 82 (12_Supplement), 2782-2782, 2022 | | 2022 |
Characterizing Targeted Therapeutic Delivery and Cellular Dynamics using In Vitro Cancer Disease Models C Uhl Lehigh University, 2018 | | 2018 |